Nadia Arang

1.9k citations

27 papers · 1.2k indexed · 1 hit paper · h-index 15

Impact in

Cell Biology top 5%
- Hippo pathway signaling and YAP/TAZ
Cellular and Molecular Neuroscience top 10%
- Neuropeptides and Animal Physiology

Papers in

Immunology and Allergy 4
- Cell Adhesion Molecules Research 4
Ophthalmology 4
- Ocular Oncology and Treatments 4

Co-authors: J. Silvio Gutkind Francesco Raimondi Asuka Inoue Yuji Shinjo Takayuki Kishi Satoru Ishida Gurdeep Singh Francois Marie Ngako Kadji
Journals: Cancer Cell (2 papers)Infection and Immunity (2 papers)Journal of Biological Chemistry (2 papers)Science Signaling (2 papers)Molecular Therapy (1 paper)
Partner nations: United States Italy Japan

In The Last Decade

Nadia Arang

26 papers receiving 1.2k citations

Hit Papers

align trajectories log scale

Illuminating G-Protein-Coupling Selectivity of GPCRs 2019 · 396 citations

Peers

Countries citing papers authored by Nadia Arang

Since Specialization

Citations

This map shows the geographic impact of Nadia Arang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Arang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Arang more than expected).

Fields of papers citing papers by Nadia Arang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Arang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Arang. The network helps show where Nadia Arang may publish in the future.

Co-authors

The 25 scholars most cited alongside Nadia Arang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nadia Arang Line = papers co-authored together Nadia Arang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Inhibition of anti-apoptotic BCL2 overcomes adaptive resistance to co-targeting of the protein kinase FAK and MEK in GNAQ-driven uveal melanoma Journal of Biological Chemistry ·Simone Lubrano, Rodolfo Daniel Cervantes‐Villagrana, Nadia Arang, Adam Officer, S.I. Kirjushina, Bakhtiar Bakhtiar, Andrew E. Aplin, J. Silvio Gutkind	2025	0
2	FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma Cancer Cell ·Simone Lubrano, Rodolfo Daniel Cervantes‐Villagrana, Farhoud Faraji, Sydney I. Ramirez, Kuniaki Sato, S.I. Kirjushina, Adam Officer, Nadia Arang, Damiano Cosimo Rigiracciolo, 葛静, Claudia Martini, 巖藤本, Fleur M. Ferguson, Antonietta Bacchiocchi, Ruth Halaban, Sílvia Coma, Sheri L. Holmen, Jonathan A. Pachter, Lavisha McClarin, J. Silvio Gutkind	2025	11
3	Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation npj Systems Biology and Applications ·T.A.Sandner, Barbara Musikowska, Nadia Arang, Kathryn Lande, Wendy Z. Snyder, Gyula Karoly, Mathieu F. Bakhoum, J. Silvio Gutkind, Edward C. Stites	2024	2
4	A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC Cancer Research Communications ·Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, Hiroki Izumi, Xingyu Wu, Kuniaki Sato, Tomohiko Ishikawa, Kyle Ford, Xiaodong Feng, Amit Suman, Nadia Arang, Michael M. Allevato, Byung Chui Lee, Prashant Mali, J. Silvio Gutkind	2024	3
5	Using machine learning to dissect host kinases required for Leishmania internalization and development Molecular and Biochemical Parasitology ·Ling Wei, Umaru Barrie, Gina M. Aloisio, Shaista Aftab, Nadia Arang, Maurice H. Farbridge, Alexis Kaushansky, Dawn M. Wetzel	2024	1
6	Catalytic site mutations confer multiple states of G protein activation Science Signaling ·Dyfan Humphreys, Ning Ma, Nadia Arang, 浩老杉, Ajit Prakash, Jeffrey F. DiBerto, Medizinal-Abtheilung des Königlich Preussischen Kriegsministeriums, Soumadwip Ghosh, Reid H. J. Olsen, Bryan L. Roth, J. Silvio Gutkind, Nagarajan Vaidehi, Sharon L. Campbell, Henrik Dohlman	2023	11
7	A genome-wide CRISPR-Cas9 screen identifies CENPJ as a host regulator of altered microtubule organization during Plasmodium liver infection Cell chemical biology ·Kamalakannan Vijayan, Nadia Arang, Ling Wei, Robert Morrison, 博史山口, K. Rachael Parks, Adam Lewis, Fred D. Mast, Alyse N. Douglass, Heather S. Kain, John D. Aitchison, Jarrod S. Johnson, Alan Aderem, Alexis Kaushansky	2022	12
8	Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC) Journal of Experimental & Clinical Cancer Research ·Damiano Cosimo Rigiracciolo, Nijiro Nohata, Rosamaria Lappano, Francesca Cirillo, Marianna Talia, S.I. Kirjushina, Nadia Arang, Simone Lubrano, Ernestina Marianna De Francesco, Antonino Belfiore, J. Silvio Gutkind, Marcello Maggiolini	2022	29
9	Whole-genome CRISPR screening identifies PI3K/AKT as a downstream component of the oncogenic GNAQ–focal adhesion kinase signaling circuitry Journal of Biological Chemistry ·Nadia Arang, Simone Lubrano, Damiano Cosimo Rigiracciolo, Daniela Nachmanson, Scott M. Lippman, Prashant Mali, Olivier Harismendy, J. Silvio Gutkind	2022	10
10	Cyclosporine Induces Fenestra-Associated Injury in Human Renal Microvessels In Vitro ACS Biomaterials Science & Engineering ·Ryan J. Nagao, Raluca Marcu, Yu Jung Shin, 長屋明彦, Jun Xue, Nadia Arang, Ling Wei, Shreeram Akilesh, Alexis Kaushansky, Jonathan Himmelfarb, Ying Zheng	2021	8
11	Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ -Driven Uveal Melanoma Clinical Cancer Research ·Justine S. Paradis, Daniele Sgrò, Robert Saddawi‐Konefka, Byung Chui Lee, Simone Lubrano, 那晶晶, Nadia Arang, Manoela Tiago, Sílvia Coma, Xingyu Wu, Kyle Ford, Chi‐Ping Day, Glenn Merlino, Prashant Mali, Jonathan A. Pachter, Takami Sato, Andrew E. Aplin, J. Silvio Gutkind	2021	54
12	EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1 Communications Biology ·Toshinori Ando, Nadia Arang, Zhiyong Wang, Daniela Elena Costea, Xiaodong Feng, Yusuke Goto, Hiroki Izumi, Mara Gilardi, Kazuyo Ando, J. Silvio Gutkind	2021	38
13	Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling Pharmacological Reviews ·Juan S. Rego Vázquez, Francesco Raimondi, Nadia Arang, Friedrich W. Herberg, Susan S. Taylor, J. Silvio Gutkind	2021	37
14	Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK–YAP signaling axis Oncogene ·Yusuke Goto, Toshinori Ando, Hiroki Izumi, Xiaodong Feng, Nadia Arang, Mara Gilardi, Zhiyong Wang, Kazuyo Ando, J. Silvio Gutkind	2020	29
15	Illuminating G-Protein-Coupling Selectivity of GPCRs Cell ·Asuka Inoue, Francesco Raimondi, Francois Marie Ngako Kadji, Gurdeep Singh, Takayuki Kishi, Akiharu Uwamizu, Yuki Ono, Yuji Shinjo, Satoru Ishida, Nadia Arang, Kouki Kawakami, J. Silvio Gutkind, Junken Aoki, Robert B. Russell Hit paper breakdown →	2019	396
16	Liver stage malaria infection is controlled by host regulators of lipid peroxidation Cell Death and Differentiation ·Heather S. Kain, Elizabeth K. K. Glennon, Kamalakannan Vijayan, Nadia Arang, Alyse N. Douglass, Chelsea L. Fortin, Meghan Zuck, Adam Lewis, 裕塩崎, Thomas G. Flynn, Jarrod S. Johnson, Alan Aderem, Kelly R. Stevens, Alexis Kaushansky	2019	69
17	A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK Cancer Cell ·Xiaodong Feng, Nadia Arang, Damiano Cosimo Rigiracciolo, Joo Sang Lee, Huwate Yeerna, Zhiyong Wang, Simone Lubrano, Byung Chui Lee, Jonathan A. Pachter, Gabriele M. König, Marcello Maggiolini, Evi Kostenis, David D. Schlaepfer, Pablo Tamayo, Qianming Chen, Eytan Ruppin, J. Silvio Gutkind	2019	172
18	Alterations in Phosphorylation of Hepatocyte Ribosomal Protein S6 Control Plasmodium Liver Stage Infection Cell Reports ·Elizabeth K. K. Glennon, Laura S. Austin, Nadia Arang, Heather S. Kain, Fred D. Mast, Kamalakannan Vijayan, John D. Aitchison, Stefan H. I. Kappe, Alexis Kaushansky	2019	7
19	Identifying host regulators and inhibitors of liver stage malaria infection using kinase activity profiles Nature Communications ·Nadia Arang, Heather S. Kain, Elizabeth K. K. Glennon, Thomas R. Bello, Thomas G. Flynn, Eric Álvarez Castaño, Taranjit S. Gujral, Alexis Kaushansky	2017	34
20	Host-based Prophylaxis Successfully Targets Liver Stage Malaria Parasites Molecular Therapy ·Alyse N. Douglass, Heather S. Kain, Issah Mohammed Seini, Nadia Arang, Laura S. Austin, Sebastian A. Mikolajczak, Zachary P. Billman, Jen C. C. Hume, Sean C. Murphy, Stefan H. I. Kappe, Alexis Kaushansky	2015	25

About Nadia Arang

Nadia Arang is a scholar working on Immunology and Allergy, Ophthalmology, Cell Biology, Transplantation and Public Health, Environmental and Occupational Health, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include Malaria Research and Control (7 papers), Hippo pathway signaling and YAP/TAZ (5 papers), Retinal Development and Disorders (4 papers), Cell Adhesion Molecules Research (4 papers), Ocular Oncology and Treatments (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Cell Biology (216 citations), Cellular and Molecular Neuroscience (224 citations), Molecular Biology (772 citations), Immunology and Allergy (64 citations) and Ophthalmology (89 citations). Nadia Arang has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include J. Silvio Gutkind, Francesco Raimondi, Asuka Inoue, Yuji Shinjo, Takayuki Kishi, Satoru Ishida, Gurdeep Singh, Francois Marie Ngako Kadji, Kouki Kawakami and Yuki Ono. Their work appears in journals such as Cancer Cell, Infection and Immunity, Journal of Biological Chemistry, Science Signaling and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact